Skip to main content

Genospectra Licenses Affymetrix Bead Technology for RNA Quantification

NEW YORK, Nov. 11 (GenomeWeb News) - Genospectra has taken a non-exclusive license to Affymetrix patents related to bead technology and gene-expression analysis, the two companies said yesterday afternoon.

Genospectra will use the technology with its signal-amplification techniques to develop methods to quantify RNA directly from cell lysates or tissue homogenates.


Financial details were not disclosed.


In April, Affymetrix said it would begin offering "reasonable terms" and would license or sell in "selected areas" some of its most recently issued patents, as well as some early patents relating to bead-based molecular technologies.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.